Source document

Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-label Drug Marketing

U.S. Department of Justice, Office of Public Affairs · Government · 27 Apr 2010 · United States

Has everything in it been taken?

CompleteReviewed 8 Oct 2026

Reviewed. Everything in it that belongs in the tables has been taken.

What the document holds

DOJ press release (27 Apr 2010), AstraZeneca $520 million civil settlement over Seroquel (federal $301,907,007; states up to $218,092,993); qui tam suit in E.D. Pa.; whistleblower James Wetta receives more than $45 million; HEAT: FCA recoveries since January 2009 (almost $2.8 billion health care; over $3.75 billion total). Already in the data: 1 case. Added: 2 cumulative FCA recovery observations.

What it supports

3 rows on this site come from this document. Each one opens with the page and the exact words.

2 numbers 1 case

Numbers (2)

Cases and awards (1)

AstraZeneca LP and AstraZeneca Pharmaceuticals LPUSD 45,000,00027 Apr 2010 · Money collected USD 520,000,000SettledUnited States · False Claims Act qui tam provisions

About the document

What it covers Settlement announcement incl. federal share and (where stated) the relator share.

Notes Copy in raw/ is the Wayback Machine capture (archive_url); justice.gov served a bot-check page to scripted requests, not bypassed.

Source id usa-doj-pr-astrazeneca-2010 · accessed 3 Oct 2026